ASX:RAC - Racura teams with Purdue Uni to advance cancer drug candidate

Racura Oncology InvestorHub

Racura teams with Purdue Uni to advance cancer drug candidate

Racura and Purdue University in US partner for molecular level studies on how (E,E)-bisantrene binds to the MYC-G4 DNA structure. Read the full article here.

Your question will be sent privately to Racura Oncology. The company may choose to make this question public.

Start the conversation

Ask Racura Oncology a question about this update.

Share your feedback

Discover